Eligo Bioscience is a startup based in France.
Eligo Bioscience (Eligo) is a French biotech based at the Institut Pasteur in Paris that develops targeted microbiome therapies by engineering bacteriophage-derived particles to deliver CRISPR-based systems for selective elimination or modulation of bacterial strains.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.